BETA

IPO registrations (S-1, F-1) · Registrants

Celularity Inc

SEC CIK
1752828 · filings on EDGAR ↗
Former names
GX Acquisition Corp. (2018–2021)
Registration
Form S-1, first filed 2019-04-26, last 2025-12-31; 7 initial registrations, 3 amendments
Outcome
Final prospectus filed 2019-05-21; declared effective 2019-05-20; withdrawal requested 2022-05-17
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
170 PARK AVE, Florham Park, NJ 07932
EIN
83-1702591
Ticker
CELU (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Celularity Inc on the corporate pages

Offering terms

Final price
$10.00 per share (424B4 filed 2019-05-21, an initial public offering)
Shares sold
25,000,000
Gross proceeds
$250,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol GXGX
Lead underwriters
J.P. Morgan
Syndicate
Cantor Fitzgerald

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 25

FiledFormWhat it isName as filedEDGAR
2019-04-26S-1S-1 (registration)GX Acquisition Corp.0001213900-19-007206 ↗
2019-05-13S-1/AS-1/A (amendment)GX Acquisition Corp.0001213900-19-008444 ↗
2019-05-20EFFECTEFFECT (declared effective)GX Acquisition Corp.9999999995-19-001154 ↗
2019-05-21424B4424B4 (final prospectus)GX Acquisition Corp.0001213900-19-009299 ↗
2021-06-25EFFECTEFFECT (declared effective)GX Acquisition Corp.9999999995-21-002527 ↗
2021-08-06S-1S-1 (registration)Celularity Inc0001213900-21-040814 ↗
2021-08-12EFFECTEFFECT (declared effective)Celularity Inc9999999995-21-003196 ↗
2022-04-07EFFECTEFFECT (declared effective)Celularity Inc9999999995-22-000858 ↗
2022-04-29S-1S-1 (registration)Celularity Inc0001193125-22-130204 ↗
2022-05-11S-1/AS-1/A (amendment)Celularity Inc0001193125-22-146808 ↗
2022-05-17RWRW (withdrawal request)Celularity Inc0001193125-22-153150 ↗
2022-05-25S-1S-1 (registration)Celularity Inc0001193125-22-158801 ↗
2022-05-31EFFECTEFFECT (declared effective)Celularity Inc9999999995-22-001649 ↗
2022-08-18EFFECTEFFECT (declared effective)Celularity Inc9999999995-22-002435 ↗
2022-08-23EFFECTEFFECT (declared effective)Celularity Inc9999999995-22-002467 ↗
2022-08-23EFFECTEFFECT (declared effective)Celularity Inc9999999995-22-002468 ↗
2023-06-02EFFECTEFFECT (declared effective)Celularity Inc9999999995-23-001623 ↗
2025-01-30S-1S-1 (registration)Celularity Inc0001493152-25-004313 ↗
2025-02-13S-1/AS-1/A (amendment)Celularity Inc0001493152-25-006219 ↗
2025-02-14EFFECTEFFECT (declared effective)Celularity Inc9999999995-25-000475 ↗
2025-03-10RWRW (withdrawal request)Celularity Inc0001493152-25-009644 ↗
2025-12-19S-1S-1 (registration)Celularity Inc0001493152-25-028562 ↗
2025-12-29EFFECTEFFECT (declared effective)Celularity Inc9999999995-25-003943 ↗
2025-12-31S-1S-1 (registration)Celularity Inc0001493152-25-029802 ↗
2026-01-07EFFECTEFFECT (declared effective)Celularity Inc9999999995-26-000103 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2019-05-13S-1/Aregistration statement$25.00--0primary document; price sentencedocument ↗
2019-05-21424B4final prospectus$10.0025,000,000$250,000,000Nasdaq GXGX2primary document; price sentence, shares headline, proceeds table, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Bloom Jay RDirector; Director,OfficerCo-CEO and Chairman32019–2021
GX Sponsor LLCTenPercentOwner22019–2021
Kehler Dean CDirector; Director,OfficerCo-CEO and Chairman62019–2025
Kellett Andrea J.OfficerChief Financial Officer12019
LEVY PAUL SDirector12019
Maselli Michael GOfficerVice President of Acquisitions12019
Mazur MarcDirector52019–2023
Weinberger HillelDirector12019
Beers David COfficerChief Financial Officer102021–2025
Brigido StephenOfficerPres, Functional Regeneration; Pres., Functional Regeneration122021–2026
Diamandis PeterDirector132021–2026
Dunn KearyOfficerGeneral Counsel & Business Dev; General Counsel & EVP; See Remarks52021–2022
Glover BradleyDirector,Officer; OfficerChief Technical Officer; Chief Technology Officer; See Remarks72021–2023
Haines John ROfficerChief Operations & Admin Offcr; Chief Ops & Admin Officer; See Remarks; Senior Exec Vice President112021–2026
Hariri Robert JDirector,Officer; OfficerChief Executive Officer162021–2026
Jones AnneDirector,Officer; OfficerChief Business Officer52021–2022
Lim Kok ThayDirector; Director,TenPercentOwner; TenPercentOwner112021–2025
SCULLEY JOHNDirector62021–2023
Smith Robin LDirector62021–2023
VON ESCHENBACH ANDREW C.Director62021–2023
Sorrento Therapeutics, Inc.TenPercentOwner22021–2023
Dragasac LtdTenPercentOwner32021–2025
Genting BerhadTenPercentOwner72021–2025
STARR INTERNATIONAL CO INCTenPercentOwner32021–2022
Starr International Investments Ltd.TenPercentOwner22021–2022
Mirakhur BelooOfficerEVP, Clinical Development22021
Pecora Andrew LOfficerPresident22021
Parks Diane L.Director102022–2026
Fletcher KyleOfficerGeneral Counsel; See Remarks92022–2024
Kilcoyne AdrianOfficerChief Medical Officer; See Remarks52022–2024
Ling Geoffrey M.D.Director82023–2026
BERMAN RICHARD JDirector32024–2025
Resorts World Inc Pte. Ltd.TenPercentOwner22024–2025
LeVien VincentDirector62025–2026
DosSantos JosephOfficerInterim CFO12025
Barach Daniele WolfTenPercentOwner32026
Barach Philip AlanDirector,TenPercentOwner; TenPercentOwner32026
Philip & Daniele Barach Family TrustTenPercentOwner32026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2025-11-03Celularity IncBiotechnology$6,666,667$2,000,00011
2025-08-05Celularity IncBiotechnology$6,812,230$6,812,23011
2025-08-05Celularity IncBiotechnology$2,000,000$2,000,00011
2025-08-05Celularity IncBiotechnology$1,035,000$1,035,000141
2022-05-27Celularity IncBiotechnology$30,000,007$30,000,00711

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationCelularity Inc.NJState business registriesname and state
Business registrationCelularity Inc.NJState business registriesname and state
Business registrationCelularity Inc.NJState business registriesname and state
Business registrationCELULARITY INC.NJState business registriesname and state
Business registrationCELULARITY INC.NJState business registriesname and state
Business registrationCELULARITY LLCNJState business registriesname and state
Plan sponsorCELULARITY INC.NJForm 5500 (employee benefit plans)name and state
Plan sponsorCELULARITY LLCNJForm 5500 (employee benefit plans)name and state
Federal award recipientCELULARITY LLCNJFederal spending (USAspending)name and state
Form D issuerCelularity IncNJForm D private offeringsCIK (EXACT)
Form D issuerCelularity Inc.NJForm D private offeringsname and state
Lobbying clientCELULARITY, INC.NJFederal lobbying (LDA)name and state
Paying companyCelularity Inc.NJOpen Payments (drug and device company payments)name and state
Patent assigneeCelularity Inc.NJPatents (USPTO)name and state
SEC filerCelularity IncSEC filers (EDGAR)CIK (EXACT)
Trademark ownerCelularity, Inc.NJTrademarks (USPTO)name and state

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NJ first:

More with this interest.

In other datasets, the same topic (Health) in NJ:

Interests: Pharmaceutical Preparations · Health